Ketamine clinics are increasing in number in the United States and globally. As we described previously, ketamine is a Schedule III drug under the federal Controlled Substances Act, has been approved by the Food and Drug Administration (FDA) for certain medical uses, and may in some cases be used for off-label uses (such as anxiety […]

The post Ketamine Clinics and the Corporate Practice of Medicine in California appeared first on Harris Bricken.

In prior blog posts (see here and here), I described how we have been fielding regular inquiries regarding international cannabis, both from companies inside the U.S. looking internationally and from international companies looking to the U.S. market. This post deals with taxation issues for international companies seeking to enter the U.S. market. Tax Treaties. The […]

The post International Cannabis: Guidance for Companies Entering the U.S. Market, Part 2 – Taxation appeared first on Harris Bricken.